Form 4 for TELA TELA Bio, Inc.
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-15 · accession 0000899243-21-048822 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-12-17 | 2021-12-15+ | TELA | EW Healthcare Partners Fund 2-UGP, LLC | 10% | P - Purchase | $12.44 | +10.1K | 1.89M | +0.5% | +$125.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2021-12-16 | P | A | 5,050 | $12.45 | 1,896,000 | I See footnotes | — | — | (F1) The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 1,984 shares of the amounts shown above for December 15 and December 16, respectively, and Fund 2-A purchased 3,035 and 3,066 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 786,847 shares and Fund 2-A now holds a total of 1,109,153 shares of the Issuer. (F2) EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. |
| 2 | Common | Common Stock, par value $0.001 per share | 2021-12-15 | P | A | 5,000 | $12.43 | 1,890,950 | I See footnotes | — | — | (F1) The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,965 and 1,984 shares of the amounts shown above for December 15 and December 16, respectively, and Fund 2-A purchased 3,035 and 3,066 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 786,847 shares and Fund 2-A now holds a total of 1,109,153 shares of the Issuer. (F2) EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. |